[Should lipid-lowering drugs be administered to normolipemic or mild hyperlipemic patients with coronary risk factors? Arguments against]

Rev Esp Cardiol. 1996 Jul;49(7):486-91.
[Article in Spanish]
No abstract available

MeSH terms

  • Coronary Disease / etiology
  • Coronary Disease / prevention & control*
  • Cost-Benefit Analysis
  • Humans
  • Hyperlipidemias / complications
  • Hyperlipidemias / drug therapy*
  • Hypolipidemic Agents / therapeutic use*
  • Primary Health Care / economics
  • Risk Factors
  • Severity of Illness Index

Substances

  • Hypolipidemic Agents